Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

[Summary] 国内分子诊断试剂生产的龙头企业之一

上海之江生物科技股份有限公司(证券代码:688317)是一家专业从事生物医药分子诊断试剂及仪器设备的研发、生产和销售的高新技术企业,2020年营收超20亿元,是业内龙头企业之一。且在*近三次全球突发公共卫生事件中三次均获得WHO认证并列入其官方采购名录的企业。 公司曾获国家技术发明奖、产学研合作创新奖等奖项10余项,参与20余项国家及上海市级项目。公司研制的产品系列包括自动化检测设备和检测诊断试剂产品,覆盖国内所有法定传染病,主要应用于医学临床、公共卫生突发事件、出入境检验检疫、食品检验等多个领域检测。目前,公司致力于自动化智能设备、各类诊断试剂、创新药及关键原材料的研发创新,丰富公司的研发产品线,增强公司的核心竞争力。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

之江生物 Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal: 上交所

之江生物 How Fast Is Hiring Growing? (74 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 178%
  • 2024: Up 37%
  • 2023: Down 68%
  • 2022: Down 21%
之江生物 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
之江生物 Campus Recruitment & Advanced Degree Talent Demand
Master's 3 Doctorate 1
Note: How fast is hiring at 上海之江生物科技股份有限公司 growing? 之江生物2025年164个(增长178%),2024年59个(增长37%),2023年43个(下降68%),2022年133个(下降21%),2021年168个. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

之江生物 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 38%
  • 2024: Up 44%
  • 2023: Up 13%
  • 2022: Up 14%
之江生物 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 上海之江生物科技股份有限公司 growing? 之江生物历年硕士招聘职位量:2025年18个(增长38%),2024年13个(增长44%),2023年9个(增长13%),2022年8个(增长14%),2021年7个. 之江生物在上海硕士人才需求中排名第652, 之江生物硕士工资大部分在10-30K.

之江生物 Doctoral Degree Job Demand Analysis

(More)
-56%
Growth Rate
2026 vs 2025
  • 2025: Up 350%
  • 2024: Down 33%
  • 2023: Up 200%
之江生物 Doctoral Hiring by Year: 2026 — 5 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 上海之江生物科技股份有限公司 growing? 之江生物历年博士招聘职位量:2026年4个(下降56%),2025年9个(增长350%),2024年2个(下降33%),2023年3个(增长200%),2022年1个. 之江生物在上海博士人才需求中排名第174, 之江生物博士工资大部分在20-50K.

之江生物 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 上海之江生物科技股份有限公司? Based on an analysis of 之江生物's job postings over the past year, “医疗卫生/美容保健类”需求占18.7%,“其他(研发和技术类)”占10.5%,“计算机/网络/技术类”占6.4%,“生物/制药/化工/环保类”占4.7%,“机械/仪器仪表类”占4.1%,“科研类”占4.1%. For reference only.

之江生物 — What Are the Salaries Like? (171 records)

Manage
之江生物 Salary Overview
salary range: 4.5K - 50K, 65.5% of roles pay ¥8-15K
Note: salary statistics are based on 171 salary records from the past year and depend on the job sample. For reference only.
上海之江生物科技股份有限公司工资待遇怎么样?之江生物65.5%的岗位拿8-15K,本科工资¥。与同行业比-30%,销售类平均工资¥10.2K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 之江生物

(More)
Are salaries high at 上海之江生物科技股份有限公司? We provide: 客户经理,销售,临床,开发工程师,国际贸易,市场,技术开发,机械工,贸易专员,省区经理,研发工程师,研究员,经理助理,业务助理,医疗器械,大客户,bd,俄语,嵌入式,德语. Click to view detailed salary analysis by job.

之江生物 — Fortune 500? (More)

之江生物 honors, qualifications & industry associations

之江生物 Related Industry Tags

Job Category

  • 销售类
    70.9% of total 70.9%
  • 医疗卫生/美容保健类
    18.6% of total 18.6%
  • 客户服务类
    18.6% of total 18.6%
  • 其他(研发和技术类)
    10.5% of total 10.5%

Education

  • 大专
    47.7% of total 47.7%
  • 本科
    33.7% of total 33.7%
  • 硕士
    10.5% of total 10.5%
  • 博士
    6.4% of total 6.4%

Experience

  • 不限
    36% of total 36%
  • 3-5年
    29.7% of total 29.7%
  • 1-3年
    28.5% of total 28.5%
  • 5-10年
    5.8% of total 5.8%
View Detailed Analysis

What does 上海之江生物科技股份有限公司 require? Who is 之江生物 hiring? 之江生物招聘类别销售类占比最多占70.9%,其次是医疗卫生/美容保健类占18.6%。之江生物什么学历能进?大专占比最多占47.7%,其次是本科占33.7%。之江生物学历要求高吗?硕士占10.5%,博士占6.4%。工作经验之江生物有什么要求?不限占比最多占36%,其次是3-5年占29.7%。之江生物工作地区在哪?上海占比最多占52.9%,其次是南昌占4.7%。 Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 19,215.7999万(元)
Legal Representative: 邵俊斌
Date Established:
Credit Code: 913100007743014560
Registered Address: 上海市张江高科技产业东区瑞庆路528号20幢乙号1层、21幢甲号1层

Partners & Suppliers

英特集团承担之江生物新冠检测试剂及分子诊断产品在浙江的冷链物流 Source
合作客户 诊断试剂供应商
2021年签订新冠核酸检测试剂盒采购合同,向之江生物采购大量试剂 Source
合作客户 第三方医学检验机构
之江生物与QIAGEN合作,基于其QIAstat-Dx多重检测平台开发诊断试剂,并采购平台设备 Source
供应商 实时荧光定量PCR仪及平台
耐优生物向之江生物供应核酸检测原料(如抗原抗体、酶等) Source
供应商 分子诊断试剂
京东健康与之江生物合作,上线线上预约核酸检测服务,由之江生物提供检测试剂与检测能力 Source
合作客户 互联网医疗客户

People who follow 之江生物 also follow

之江生物 Competitors (Similar Companies)

“医疗设备和医疗信息化解决方案提供商”
“开发老百姓都用得着、用得起的高质量的生物药”
“以科学的态度尊重生活快乐的价值”
“快速检测产品研发生产商”
“致力于为中国家庭提供国际标准的医疗服务”
医疗器械 生产 健康产业 医用高分子材料
制药/药业 制药 生物制品 中成药
“中国肝病、抗肿瘤领域的知名企业”
生物工程 医疗耗材 植入医疗器械 凝胶
“让所有人拥有美”
“领先的心脑血管和外周血管微创介入医疗器械企业”
“主要从事医用耗材智能装备的研发、生产、销售”
“致力推进智能制造,共同实现产业升级”
“一家致力于中成药、化学药及生物制品的研发、生产、销售及售后服务的医药集团”
电池模组 机器人系统集成 激光焊接机 工业自动化

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates

心理援助
客服
由百度提供